Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Cariprazine manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

4 products found

cariprazine

Capsules 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, WHO
Manufacturer #15897
This pharmaceutical company specializes in developing and manufacturing solid dosage forms like tablets, capsules, and ready-to-fill pellets for generic drug formulations. They boast a vertically integrated business model spanning research, development, manufacturing, and marketing across multiple therapeutic segments. With state-of-the-art facilities strategically located in various regions, including North America and the EU, they offer a wide range of products encompassing prescription medications, over-the-counter drugs, and potential medical devices. The company is committed to quality assurance, as evidenced by their GMP certifications from prestigious bodies like the WHO and US FDA. They hold several patents for their innovative drug formulations and delivery systems, contributing to their competitive advantage in the global market. They hint at a focus on acute and chronic conditions with expertise in novel drug delivery systems.

Manufacturer usually replies in 3 days

cariprazine

Capsules 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Established in 2004, this vertically integrated pharmaceutical manufacturer is committed to delivering high-quality, affordable medicines globally. As a CTD dossier owner and manufacturer, it holds GMP certifications from the US FDA, EU, and WHO, ensuring compliance with stringent international quality standards. The company's state-of-the-art R&D center is capable of handling oral solids, liquids, and parenteral formulations. Its products have received marketing authorizations from regulatory authorities such as the US FDA, Health Canada, CDSCO-India, and New Zealand. With over 20 ANDA/ANDs under approval, the manufacturer operates advanced production lines adhering to rigorous GMP guidelines. Its diverse portfolio includes therapeutics in areas like antivirals, neurology, women's health, cardiology, and imaging contrast agents.

Manufacturer usually replies in 2 days

cariprazine

Tablets 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, Vietnam, Kenya, Myanmar, Chile, Nigeria, Uganda, Afghanistan, Cambodia, Yemen, Philippines, Salvador, Malawi
Manufacturer #19280

Manufacturer usually replies in nan days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible